Skip to main content

Table 3 Intervention for patients with declining ALSFRS-R

From: How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study

Bulbar ALS

62.5%

Gastrostomy

3/8 (37.5%)

Botox injection

2/8 (25%)

NIV

8/8 (100%)

  1. NIV non-invasive ventilation